Recent Quotes (30 days)

You have no recent quotes
chg | %

Medicure Inc.  

(Public, CVE:MPH)   Watch this stock  
Find more results for CVE:MPH.H
-0.15 (-5.58%)
Delayed:   3:06PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.54 - 2.65
52 week 0.13 - 3.15
Open 2.54
Vol / Avg. 7,744.00/7,651.00
Mkt cap 30.99M
P/E     -
Div/yield     -
EPS 0.00
Shares 12.20M
Beta 0.12
Inst. own 5%

Key stats and ratios

Q2 (May '14) 2014
Net profit margin -41.09% -32.45%
Operating margin 22.09% 3.26%
EBITD margin - 14.37%
Return on average assets -77.05% -46.62%
Return on average equity - -
Employees 4 -
CDP Score - -


2-1250 Waverley Street
+1-204-4877412 (Phone)
+1-204-4889823 (Fax)

Website links


Medicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company�s primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company�s United States subsidiary, Medicure Pharma, Inc.

Officers and directors

Albert D. Friesen Ph.D. Chairman of the Board, Chief Executive Officer
Age: 66
Dawson J. Reimer President, Chief Operating Officer
Age: 43
James F. Kinley CA Chief Financial Officer
Age: 35
Brent Fawkes Director
Gerald P. McDole Independent Director
Age: 74
Arnold Naimark MD,LLD Independent Director
Age: 80
Peter Quick Independent Director
Age: 58